
Welcome back to another episode of The Red Leaf Podcast — where we dive deep into the stories behind Australia’s most dynamic companies and the leaders shaping their futures. I’m your host, and today we’ve got a special guest joining us to unpack one of the most intriguing biotech names on the ASX.Jason Hine is the Executive Director and Chief Operating Officer of Bioxyne Limited, listed on the ASX as BXN — a company focused on advancing evidence-based wellness solutions and unlocking scientific value from natural biopolymers. With over three decades of leadership experience across operations, commercial strategy and scaling high-growth businesses, Jason brings a wealth of insight into how Bioxyne is navigating the intersection of science, health and markets.Today we’ll explore the company’s strategy, market opportunities, commercial milestones and what’s next on the roadmap for BXN. Whether you’re an investor, entrepreneur or just passionate about biotech innovation — you’re in for a great conversation.Jason — welcome to the Red Leaf Podcast!Become a supporter of this podcast: https://www.spreaker.com/podcast/red-leaf-securities--6387900/support.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Red Leaf with Australian Vintage (AVG) CEO Tom Dusseldorp

Red Leaf with RocketDNA Ltd (RKT) CEO Chris Clark

Red Leaf with X2M Connect Ltd CEO Mohan Jesudason

Red Leaf with DXN Ltd CEO Shalini Lagrutta
Free AI-powered recaps of Red Leaf Securities and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.